Securities Law Firm

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $8 Million Underwritten Public Offering of Common Stock of Forza XI, Inc.

Press Release – New York, NY – June 15, 2023 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity LLC in the public offering of the common stock of Forza XI, Inc. (NASDAQ:FRZA), a developer of electric sport boats aimed at promoting sustainable recreational boating. The offering consisted of 5,334,000 shares of its common stock at a public offering price of $1.50 per share, for gross proceeds of $8 million. The Company has granted the underwriter a 45-day option to purchase up to an additional 800,100 shares of common stock to cover over-allotments at the public offering price.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Jay Yamamoto, and associate Mayank Pradhan.

Sichenzia Ross Ference LLP Represents Wang & Lee Group, Inc. in $8 Million Initial Public Offering of Ordinary Shares

Press Release – New York, NY –April 25, 2023 – Sichenzia Ross Ference LLP announced today that it represented Wang & Lee Group, Inc. in an $8 million initial public offering of ordinary shares (NASDAQ: WLGS), a Hong Kong-based construction prime and subcontractor engaging in the installation of Electrical & Mechanical Systems. The initial public offering consisted of 1,600,000 ordinary shares issued and sold by Wang & Lee Group, Inc. at the public offering price of $5.00 per share.

Boustead Securities, LLC acted as the underwriter.

The Sichenzia Ross Ference LLP team was led by partner Benjamin Tan.

Sichenzia Ross Ference LLP Represents EF Hutton in $57.5 Million Initial Public Offering of Cetus Capital Acquisition Corp.

Press Release – New York, NY – February 6, 2023 – Sichenzia Ross Ference LLP announced today that it represented EF Hutton, division of Benchmark Investments LLC, in a $57.5 Million Initial Public Offering of Cetus Capital Acquisition Corp (NASDAQ: “CETUU”). The offering consisted of 5,750,000 units, including the underwriter’s over-allotment, at $10.00 per unit and was listed on the Nasdaq Capital Market for trading on Wednesday, February 1st, 2023. Each unit consists of one share of the Company’s Class A common stock, one redeemable warrant, and one right.

The Sichenzia Ross Ference LLP team was led by partners Huan Lou, David Manno and associate Kayla Scoccola.

Sichenzia Ross Ference LLP Represents Network 1 Financial Securities, Inc. in $69 Million Public Offering of Horizon Space Acquisition I Corp.

Press Release – New York, NY – December 27, 2022 – Sichenzia Ross Ference LLP announced that it represented Network 1 Financial Securities, Inc. in the public offering of Horizon Space Acquisition I Corp. (the “Company”), a newly organized blank check company incorporated as a Cayman Islands exempted company.

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $6.87 Million Public Offering of Common Stock of Twin Vee PowerCats Co.

Press Release – New York, NY – October 3, 2022 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity LLC in the public offering of the common stock of Twin Vee PowerCats Co. (NASDAQ: VEEE), a manufacturer, distributor, and marketer of power sport catamaran boats. The offering consisted of 2,500,000 shares of its common stock at a public offering price of $2.75 per share, for gross proceeds of $6,875,000. The Company has granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments.

Sichenzia Ross Ference LLP Represents Alset Capital Acquisitions Corp. in $86.25 Million Initial Public Offering and NASDAQ Listing

Press Release – New York, NY – February 7, 2022 – Sichenzia Ross Ference LLP announced today that it represented Alset Capital Acquisition Corp. (Nasdaq: ACAXU), a newly formed blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, in its NASDAQ listing and initial public offering of 7,500,000 units at a public offering price of $10.00 per share, each unit including one Class A common stock, one half of one redeemable warrant, and one right to receive one tenth (1/10) of one share of Class A common stock upon consummation of an initial business combination. The gross proceeds from the offering, including the over-allotment option shares, were $86,250,000 before deducting underwriting discounts, commissions and offering expenses.

Sichenzia Ross Ference LLP Represents VC-backed Cyngn, Inc. in $26.3 Million Initial Public Offering

Press Release – New York, NY – October 25, 2021 – Sichenzia Ross Ference LLP announced today that it represented Cyngn, Inc., (NASDAQ: CYN) a venture capital backed developer of innovative autonomous driving software solutions for industrial and commercial enterprises, in its initial public offering. The offering consisted of 3,500,000 shares of its common stock at a public offering price of $7.50 per share, for gross proceeds of $26,300,000. Previous shareholders of CYN include Benchmark Capital, Andreessen Horowitz and Qualcomm Ventures.

Sichenzia Ross Ference LLP Represents American Battery Technology Company in $39.1 Million Financing

Press Release – New York, NY – October 4, 2021 – Sichenzia Ross Ference LLP today announced that it represented American Battery Technology Corporation (OTCQB: ABML), an American-owned critical minerals company currently building the first non-thermal integrated lithium-ion battery recycling plant in the United States, in a $39.1 million financing. The offering consisted of $39.1 million in securities with an aggregate of 25,389,611 shares of common stock and warrants at a purchase price of $1.54 per share in a registered direct offering.

Sichenzia Ross Ference LLP Represents The Glimpse Group in $14.1 Million Initial Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

Press Release – New York, NY – July 12, 2021 – Sichenzia Ross Ference LLP today announced that it represented The Glimpse Group (NASDAQ: VRAR) (Company), a diversified Virtual Reality and Augmented Reality (“VR” and “AR”) platform company providing enterprise-focused VR and AR software & services solutions, in an initial public offering of 2,012,500 shares of common stock, which included the full exercise of the underwriter’s over-allotment option. The offering was priced at $7.00 per share. The gross proceeds were approximately $14.1 million.

Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to Jiuzi Holdings Inc. $26 Million U.S. Initial Public Offering

Press Release – New York, NY – May 24, 2021 – Sichenzia Ross Ference LLP congratulates Jiuzi Holdings Inc. (the “Company”) (NASDAQ: JZXN), a new energy vehicles franchisor and retailer under the brand name “Jiuzi” in China, on the final closing of its initial public offering on May 20, 2021. The Company raised $26 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 5,200,000 ordinary shares at a public offering price of $5.00 per share. The ordinary shares commenced trading on the Nasdaq Capital Market on May 18, 2021 under the ticker symbol “JZXN.”

Sichenzia Ross Ference LLP Represents Alset EHome International Inc. in a $32.0 Million Public Offering of Units

Press Release – New York, NY – May 13, 2021 – Sichenzia Ross Ference LLP today announced that it represented Alset EHome International Inc. (NASDAQ: AEI), a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities, in a public offering. The offering consisted of 4,700,637 Units (the “Common Units”), priced to the public at $5.07 per Common Unit, with each Common Unit consisting of (a) one share of common stock, par value $0.001 per share (the “Common Stock”), (b) one Series A warrant to purchase one share of Common Stock with an initial exercise price of $5.07 per whole share and (c) one Series B warrant to purchase one-half of a share of Common Stock with an initial exercise price of $6.59 per whole share. The gross proceeds were approximately $32.0 million.

Sichenzia Ross Ference LLP Represents Aegis Capital in $48.3 Million Underwritten Public Offering of Farmmi, Inc.

Press Release – New York, NY – May 3, 2021 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 140,000,000 ordinary shares, and 21,000,000 additional shares from the exercise of the underwriter’s option to purchase such shares to cover over-allotments, of Farmmi, Inc. (NASDAQ: FAMI), a leading agricultural products supplier, processor and retailer of Shiitake mushrooms and other edible fungi. The offering was priced at $0.30 per share and the gross proceeds from the offering were $48.3 million.

Sichenzia Ross Ference LLP Represents SeaChange International, Inc. in $19.1 Million Public Offering of Common Stock

Press Release – New York, NY – April 5, 2021 – Sichenzia Ross Ference LLP today announced that it represented SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, in a public offering of 10,323,484 shares of the company’s common stock. The offering was priced at $1.85 per share, which was above the five-day average closing price of $1.26. The gross proceeds were approximately $19.1 million. Additionally, the Company has granted the underwriter an option to purchase an additional 15 percent of the common stock offered in the public offering solely to cover over-allotments, if any, exercisable for 45 days after the closing of this offering, which if exercised, would bring total gross proceeds to approximately $22.0 million.

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $97.5 Million Public Offering of Common Stock

Press Release – New York, NY – April 1, 2021 – Sichenzia Ross Ference LLP, a leading securities and law firm, today announced that it represented Vuzix Corporation (NASDAQ: “VUZI”), a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets in a public offering of 4,768,293 shares of the company’s common stock at a price of $20.50 per share, including 621,951 shares pursuant to the full exercise by the underwriters of their over-allotment option. The gross proceeds to the Company from the offering, were approximately $97.75 million.

Sichenzia Ross Ference LLP Represents Aegis Capital in $3.3 Million Follow-On Offering of MySize, Inc.

Press Release – New York, NY – March 25, 2021 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 2,618,532 shares of common stock of MySize, Inc. (NASDAQ: MYSZ), a creator of mobile device measurement solutions that has developed innovative solutions designed to address shortcomings in multiple verticals, including the e-commerce fashion/apparel, shipping/parcel and do-it-yourself (DIY) industries, at a price of $1.26 per share for gross proceeds of approximately $3.3 million.

Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $10.5 Million Registered Direct Offering of ION Geophysical Corporation

Press Release – New York, NY – February 18, 2021 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 2,990,001 shares of common stock of ION Geophysical Corporation (NYSE: IO), a company that delivers powerful data-driven decision-making to offshore energy, ports and defense industries, enabling clients to optimize operations and deliver superior returns. The offering price was $3.50 per share for gross proceeds of $10.5 million.

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $40.0 Million Registered Direct Offering of Pulmatrix, Inc.

Press Release – New York, NY – February 17, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as exclusive placement agent in a $40.0 million public offering of the common stock of Pulmatrix, Inc. (NASDAQ: “PULM”), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The registered direct offering with certain healthcare-focused institutional investors consisted of the sale 20,000,000 shares of common stock, for aggregate gross proceeds of approximately $40.0 million.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $39.7 Million Upsized Public Offering of Common Stock

Press Release – New York, NY – February 9, 2021 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 14,167,247 shares of the company’s common stock at a price of $2.80 per share, bringing the gross proceeds to approximately $39.7 million. The shares of common stock were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was declared effective by the SEC on May 8, 2019.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. as Sole Bookrunner in $14.4 Million Bought Deal Offering of Avinger, Inc. Common Stock

Press Release – New York, NY – February 2, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten offering of 10,000,000 shares of the common stock of Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $1.44 per share. The gross proceeds of the offering were approximately $14.4 million, prior to deducting underwriting discounts and commissions and estimated offering expenses.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $6 Million Public Offering of Avinger Inc. Common Stock

Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $10 Million Initial Public Offering of 1847 Goedeker Inc. Common Stock

Press Release – New York, NY – August 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole book-runner in the initial public offering of the common stock of 1847 Goedeker Inc. (NYSE: GOED), a one-stop e-commerce destination for appliances, furniture, home goods, and related products. The offering was comprised of 1,111,200 shares of common stock at a price of $9.00 per share for gross proceeds of $10,000,800, less underwriting discounts and offering expenses.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in Close of $3.4 Million Underwritten Public Offering of Common Stock

Press Release – New York, NY – July 31, 2020 – Sichenzia Ross Ference LLP represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, in a public offering of 453,333 shares of the company’s common stock at a price of $7.50 per share, for gross proceeds to DSS of $3.4 million, before deducting underwriting discounts and other offering expenses. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-230740), which was previously filed with the Securities and Exchange Commission and declared effective on May 8, 2019.

Sichenzia Ross Ference LLP Represents Zynex, Inc. and Selling Shareholder in $55 Million Public Offering of Common Stock

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP today announced that it represented Zynex, Inc. (NASDAQ: “ZYXI”), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, and a certain shareholder in a public offering of an aggregate of 2,500,000 shares of its common stock at a public offering price of $22.00 per share. The offering was made pursuant to a registration statement on Form S-3 (File No. 333-230128) that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on March 12, 2019, and a registration statement on Form S-3 (File No. 333-232367) that was filed with the SEC and became effective on July 3, 2019, for the shares of common stock being offered by ZYXI and the selling stockholder, respectively.

Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock

Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP announced that it represented INmune Bio Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, in a public offering of 2,173,914 shares of the company’s common stock at a price of $10.00 per share. The gross proceeds to INMB were $21.74 million, before deducting underwriting discounts and other offering expenses, with net proceeds estimated to be $20 million. The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-237368), that was filed with the Securities and Exchange Commission (the “SEC”) and became effective on April 2, 2020.

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.4 Million Public Offering of Digital Ally, Inc. Common Stock

Press Release – New York, NY – June 5, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,325,581 shares of the common stock of Digital Ally, Inc. (NASDAQ: DGLY), a video security company, at a price of $2.15 per share. The underwriters elected to simultaneously close the over-allotment option consisting of 213,953 shares of common stock, bringing the offering’s gross proceeds to approximately $5.4 million, before deducting underwriting discounts and other offering expenses.

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners in $8.4 Million Underwritten Public Offering of Safe-T Group Ltd.

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented A.G.P./Alliance Global Partners as sole book-running manager in an underwritten public offering of the securities of Safe-T Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions for on-premise and hybrid cloud environments. The securities offered by the company consisted of (i) 858,600 units, each comprised of one American Depositary Share (“ADS”), representing 40 ordinary shares, and one warrant to purchase one ADS (“Warrant”), and (ii) 6,777,500 pre-funded units, each comprised of one pre-funded warrant to purchase one ADS and one Warrant. The offering price was $1.10 per unit and $1.099 per pre-funded unit.

Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering

Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, in an At-The-Market Offering (“ATM”) under which the Company may offer and sell from time to time shares of its common stock having an aggregate offering price of up to $50,000,000.

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.6 Million Offering of Medalist Series A Stock

Press Release – New York, NY – February 19, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 200,000 shares of 8% Series A Cumulative Redeemable Preferred Stock of Medalist Diversified REIT, Inc. (Nasdaq:MDRR), a real estate investment trust specializing in the acquisition, ownership and management of value-add commercial real estate. The shares were sold at an offering price of $23.00 per share for gross proceeds of $4.6 million and commenced trading on the Nasdaq Capital Market under the symbol “MDRRP.”

Sichenzia Ross Ference LLP Represents ThinkEquity in $8.1 Million Offering and NASDAQ Listing of Duos Technologies Common Stock

Press Release – New York, NY – February 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager and The Benchmark Company as co-manager in an $8.1 million offering of common stock at $6.00 per share of Duos Technologies Group, Inc. (NASDAQ: DUOT). Simultaneously with the offering, the common stock was approved for listing on the Nasdaq Capital Market and began trading on February 13, 2020 under the symbol DUOT.

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Follow-On Offering of Avinger, Inc. Common Stock

Press Release – New York, NY – February 4, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the follow-on offering of 6,428,572 shares of the common stock of Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease, at an offering price of $0.70 per share for gross proceeds of $4.5 million. The shares are being offered and sold pursuant to Avinger’s effective registration statement on Form S-1 (Registration No. 333-235902).

Sichenzia Ross Ference LLP Represents HiVentures Zrt., a Hungarian Venture Capital Company, in Private Placement of Series A Preferred Stock of ActiveGraf

Press Release – New York, NY – January 16, 2020 – Sichenzia Ross Ference LLP announced today that it represented MFB Növekedési Tökealap, a Hungarian investment firm, and its manager, Hiventures Zrt., a state-owned venture capital company committed to the promotion of Hungarian start-ups and businesses, in connection with their agreement to purchase approximately $900,000 of Series A preferred stock of ActiveGraf Inc., a private North Carolina-based company creating interactive data analytics.

Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $3M Registered Direct Offering of Cellect Biotechnology Ltd.

Press Release – New York, NY – January 10, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a registered direct offering of 1,000,000 American Depositary Shares (“ADSs”) of Cellect Biotechnology Ltd (Nasdaq: “APOP”), a developer of innovative technology enabling the functional selection of stem cells. Each of the ADSs represents 100 of APOP’s ordinary shares. The offering price was $3.00 per ADS for gross proceeds of approximately $3,000,000, less fees and other estimated offering expenses.

Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement

Press Release – New York, NY – December 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: XAIR), a clinical stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for treatment of severe respiratory conditions, in the successful completion of an underwritten public offering and concurrent private placement of approximately $11.5 million of Beyond Air common stock at a price of $3.66 per share. The public offering was conducted from an effective shelf registration statement filed with the Securities and Exchange Commission. The private placement shares will not be registered.

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock

Press Release – New York, NY – December 6, 2019 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a clinical stage company developing depression and central nervous system disease therapies, in the successful completion of an underwritten public offering of three million shares of Relmada common stock at a price of $30.00 per share.

The underwriters exercised their over-allotment option for an additional 450,000 shares, bringing gross proceeds to $115 million before the deduction of underwriting discounts, commissions, and other estimated offering expenses. Jefferies, SVB Leerink, and Guggenheim Securities are joint book running managers for the offering.

Relmada intends to use the net proceeds to fund research and development for clinical stage programs related to its lead product candidate, REL-1017 (d-methadone), an oral agent for depression which recently produced favorable results in clinical trials.

Sichenzia Ross Ference LLP also represented Relmada in the listing of its Common Stock on the Nasdaq Capital Market, which commenced trading on October 10, 2019. The firm joined Relmada and its executive leadership at its Nasdaq Bell Ringing Ceremony on October 17.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Barrett DiPaolo, Thomas Rose and Associate Grant Levine.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

Press Release – New York, NY – November 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics. continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital in $4.5 Million Public Offering of Avinger, Inc. Common Stock

Press Release – New York, NY – August 26, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,813,559 shares of Avinger, Inc. (NASDAQ: AVGR) common stock, at a price of $1.18 per share for gross proceeds of approximately $4.5 million. Avinger is a leading developer of innovative treatments for peripheral artery disease.

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $2.3 Million Public Offering of Common Stock of Sigma Labs, Inc.

Press Release – New York, NY – August 2, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 2.875 million shares Common Stock of Sigma Labs, Inc. (NASDAQ: SGLB) at a price of $.80 per share for gross proceeds of $2.3 million. Sigma Labs is a provider of quality assurance software under the PrintRite3D brand.

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of approximately 5.48 million registered shares of common stock at a price of $3.65 per share and approximately 5.48 million common stock purchase warrants with an exercise price of $4.10 per share for gross proceeds to Vuzix of approximately $20 million. The Special Equities Group, a division of Bradley Woods & Co. Ltd. acted as the exclusive Placement Agent for the offering. The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Tara Guarneri-Ferrara, and Counsel Jeff Cahlon.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented its client, Document Security Systems, Inc. (NYSE American: DSS), in a $5.6 million public offering of its common stock. The offering consisted of 11.2 million shares of common stock at a price of $0.50 per share. Aegis Capital Corp. served as sole book running manager in connection with the offering. DSS is a leader in the anti-counterfeit, authentication and diversion protection technology space. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia, Darrin Ocasio, Tara Guarneri-Ferrara and Jeffrey D’Angelo.

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man or the “Company”) in a securities purchase agreement with Dye Capital & Co. for the sale of up to $14 million of shares and common stock purchase warrants of the Company. The shares were sold at a price of $2.00 per share.

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

Press Release – New York, NY – May 31, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

Sichenzia Ross Ference Represents Pareteum Corporation in $40 Million Offering of Common Stock and Warrants

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital, Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – September 27, 2019 – Nationally-recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: “TEUM”), global cloud software communications platform company, in an underwritten public offering of 18,852,273 Common Stock Units, each consisting of one share of TEUM’s common stock, one Series A Purchase Warrant to purchase one share of TEUM’s common stock, and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock, and 3,875,000 Pre-Funded Units, consisting of one pre-funded warrant to purchase one share of TEUM’s common stock together with one Series A Purchase Warrant to purchase one share of TEUM’s common stock and one Series B Purchase Warrant to purchase one-half share of TEUM’s common stock.

Sichenzia Ross Ference Kesner LLP Represents ToughBuilt Industries, Inc. in $6.1 Million Private Offering

Press Release – New York, NY – October 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented ToughBuilt Industries, Inc. (“ToughBuilt”) in a private placement of equity as well as debt securities. ToughBuilt is a private company that markets and distributes various home improvement and construction product lines for both do-it-yourself and professional markets under the TOUGHBUILT® brand name within the global multi-billion dollar per year tool market industry.

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $3 Million Private Placement

Press Release – New York, NY – October 17, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of FTE Networks, Inc. (OTCQX: FTNW), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Aridis Pharmaceuticals in $15 Million Private Placement

PRESS RELEASE – New York, NY – August 25, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, in a private placement of preferred stock and warrants resulting in total gross proceeds of $15,216,241. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $3.77 Registered Direct Offering

Press Release – New York, NY – July 11, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as the exclusive placement agent for a registered direct offering of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye (“EyeGate”).

Sichenzia Ross Friedman Ference LLP Represents Vuzix Corporation in $6.6 Million Public Offering

Press Release – New York, NY – July 11, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented Vuzix Corporation in a firm commitment underwritten public offering of shares of common stock. The offering consisted of 1,150,000 shares of common stock, including continue reading >>

Partners Marc J. Ross and James M. Turner Represent Tonix Pharmaceuticals in $10 Million Public Offering of Common Stock

Press Release – New York, NY – June 23, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the firm has represented Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a developer of next-generation medicines for common disorders of the central nervous system, continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc.

Press Release – New York, NY – June 21, 2016 – Nationally recognized securities and corporate law firm, Sichenzia Ross Friedman Ference LLP, announced today that it has represented Joseph Gunnar & Co. LLC as sole book-running manager in a firm commitment underwritten public offering of shares and warrants of Intellicheck Mobilisa, Inc.

Partners Richard A. Friedman and Stephen A. Cohen Represent Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book Running Managers of PhaseRx, Inc.’s $18.5M IPO

Press Release – New York, NY – May 23, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book-Running Managers of the initial public offering of PhaseRx, Inc. (NASDAQ: PZRX).

Sichenzia Ross Friedman Ference LLP Represents Axiom Capital Management, Inc. In $1.2 Million Public Offering of iSign Solutions Inc.

Press Release – New York, NY – May 19, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Axiom Capital Management, Inc. as the underwriter in a firm commitment underwritten public offering of equity securities of iSign Solutions Inc. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Viatar CTC Solutions Inc. in a $4.2 Million Private Placement

Press Release – New York, NY – March 3, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Viatar CTC Solutions Inc., a medical technology company focused on the treatment of patients with metastatic cancer, in a private placement of $4.2 million of Series B Preferred Stock. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $6.9 Million Private Placement

Press Release – New York, NY – February 26, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Pershing Gold Corporation (NASDAQ: PGLC), a mining company (the “Company”). In connection with the offering, the Company accepted subscriptions for the sale of approximately $6.9 million in gross proceeds of 2,120,882 Units, with each Unit comprised of 1 share of Common Stock and a 30 month warrant to acquire 0.5 of a share of Common Stock at an exercise price of $5.06, at a price of $3.25 per Unit.

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in a $3 Million Registered Direct Offering

February 24, 2016 – New York, NY – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Amarantus BioScience Holdings, Inc. in a $3 million offering of the Company’s Series H Convertible Preferred Stock and Warrants to purchase common stock.

Partner Marc Ross Represents Israeli Medical Marijuana Company OWC Pharmaceutical Research Corp. in Financing10

Press Release – New York, NY – December 30, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented OWC Pharmaceutical Research Corp. continue reading >>

Partners Darrin Ocasio and Arthur Marcus Represent CBC Biotechnologies Inc. in Series A Preferred Stock Venture Financing

Press Release – New York, NY – December 24, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that the firm has represented CBC Biotechnologies Inc., a commercial solutions provider of cannabinoid based products with applications in the fields of pharmaceuticals, nutraceuticals and cosmetics/skin care, in connection with a $2,000,000 Series A venture financing with Tuatara Capital Fund I, L.P.
continue reading >>

Partner Richard Friedman Represents eMagin Corporation in $6M Registered Direct Offering

Press Release – New York, NY – December 23, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented eMagin Corporation (NYSE MKT: EMAN) (the “Company”), the leader in the development, design and manufacture of Active Matrix OLED microdisplays for high resolution imaging products, in connection with its $6,000,000 registered direct offering. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Takung Art Co., LTD on $1.58M PIPE

Press Release – New York, NY – November 17, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that the Firm has represented Takung Art Co., a provider of an online platform for artists and creative professionals, in connection with a $1,580,000 private placement of the Company’s common stock priced at $1.58 per share.
continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Genius Brands International on $4.3M PIPE

New York, NY – November 9, 2015 – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented global content and brand management company Genius Brands International, Inc. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Oppenheimer and Co. and H.C. Wainwright as Placement Agents on UQM Technologies’ $6.4 Million Registered Direct Offering

October 30, 2015 – New York, NY – Press Release – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented investment bank Oppenheimer & Co. Inc. and Rodman and Renshaw, a division of H.C. Wainwright & Co. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Oasmia Pharmaceutical AB on $9.5M IPO and U.S NASDAQ listing

SRFF LLP Advises Fifth Swedish IPO on U.S. NASDAQ

October 28, 2015 – Press Release – New York, NY –Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today the Firm has represented Oasmia Pharmaceutical AB (NASDAQ: OASM) (NASDAQ Stockholm: OSAM.ST), a Swedish biopharmaceutical company focused on developing innovative treatments within human and animal oncology, on the company’s U.S. underwritten public offering of American Depository Shares (ADSs) and warrants to purchase the company’s ADSs at an offering price of $4.06 per ADS. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Israeli Biotech Company Can-Fite Biopharma on $4.8M Registered Direct Offering of ADSs

New York, NY – Press Release – October 15, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), an Israeli biotechnology company advancing a pipeline of proprietary small molecule drugs that addresses cancer and inflammatory diseases, on a registered direct offering with institutional investors where the Company issued 1,109,196 American Depository Shares (ADSs) at a purchase price of $4.35 per ADS. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents ContraVir Pharmaceuticals, Inc. on $15 Million Public Offering of Common Stock and Warrants

Press Release – New York, NY – October 14, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, on an underwritten public offering of 5,000,000 shares of the Company’s common stock and warrants to purchase up to 3,000,000 shares of common stock at a combined public offering price of $3.00. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Rightscorp in $1.032M PIPE

October 9, 2015 – New York, NY – Press Release – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Rightscorp, Inc., a technology company that provides monetization services for holders of copyrighted intellectual property (OTCQB:RIHT) in a private placement offering where the Company sold to accredited investors 10,320,000 shares of common stock and warrants.
continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in $5.5M Registered Direct Offering and Private Placement

October 1, 2015 — New York, NY – Press Release – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) is pleased to announce that the Firm has represented Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS), a biotechnology company developing therapeutic and diagnostic product candidates for orphan indications and neurology in a registered direct offering where Amarantus issued $2.75 million of newly designated Series H convertible preferred stock and warrants. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Israeli Company Can-Fite BioPharma on $9.0M Public Offering of ADSs

New York, NY – Press Release – September 22, 2015 –Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Israeli biotechnology company, Can-Fite BioPharma (NYSE: CANF)(TASE: CFBI) on a public offering with institutional investors where Can-Fite received $9 million in gross proceeds. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Aegis Capital as Underwriter on $3.0M Public Offering

Press Release – New York, NY – August 10, 2015 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Aegis Capital Corp. continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

Represents first Israeli-American collaborative transaction between affiliated law firms SRFF LLP and DTKGC & Co.

New York, NY – May 15, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the underwriter Aegis Capital Corp. on the U.S. initial public offering of BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV), continue reading >>

Sichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals on $2.5M Registered Direct Offering

August 4, 2015 – Press Release – New York, NY – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented DelMar Pharmaceuticals, Inc. (OTCQX: DMPI), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Trovagene, Inc. on $40.3M Public Offering of Common Stock

Press Release – New York, NY – July 22, 2015—New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Trovagene, Inc. (NASDAQ: TROV), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals Holding Corp. on $20.1M Public Offering

Press Release – New York – July 17, 2015 – New York-based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Cynata on A$5.0M Private Placement

Press Release – New York – July 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that acted as US counsel to Australian-based stem cell and regenerative medicine provider Cynata Therapeutics Limited (ASX: CYP) continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Israeli-Based Wellsense on $2.0M Private Placement

Press Release — New York, NY – July 1, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented Enhanced Surface Dynamics Inc. D.B.A Wellsense USA, continue reading >>

Sichenzia Ross Friedman Ference LLP Represents LaidLaw & Company (UK) Ltd. on $5.0M Registered Direct Offering of Actinium Pharmaceuticals, Inc

June 18, 2015 – New York, NY – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the sole placement agent Laidlaw & Company (UK) continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Co. (UK) Ltd. as Sole Book-Running Manager of Viking Therapeutics’ $24.0M IPO

New York, NY – May 6, 2015 – New York City based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (the “Firm”) announced today that the Firm has represented Laidlaw & CO. (UK) Ltd. continue reading >>

Vuzix Corp. Announces $24.8M Investment from Intel

Sichenzia Ross Friedman Ference LLP Represents Vuzix Corp. in $24.8M Investment From Intel

NEW YORK, NY –( January 5, 2015) –New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Vuzix® Corporation (OTCQB: VUZI) (“Vuzix” or the “Company”), a leading supplier of video eyewear and smart glasses products, in an investment transaction whereby Intel Corporation made a $24.8 million investment in Vuzix. Intel’s investment will be used for general working capital and will contribute to the acceleration of the introduction of Vuzix’s next generation wearable display products into the consumer market.

Intel purchased 49,626 shares of Vuzix’s Series A Preferred Stock, convertible into 4,962,600 shares of the Company’s common stock at an initial conversion price of $5.00 per share. The shares issuable on conversion of the Series A Preferred Stock represent approximately 30% of Vuzix’s outstanding stock.

The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Thomas A. Rose, Tara Guarneri Ferrara and Associate Jeffrey Cahlon.

About Sichenzia Ross Friedman Ference LLP
Sichenzia Ross Friedman Ference LLP is a securities and corporate law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. The firm’s clients range from start-ups to established, listed companies; they include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. The firm also advises institutional investors on transactions involving complex securities law considerations and its practice includes the representation of clients located in the United States and throughout the world. To learn more about Sichenzia Ross Friedman Ference LLP, visit www.srff.com, SRFF’s LinkedIn and SRFF’s Twitter: @SRFFLLP.

PlasmaTech Announces $14.0 M Public Offering and NASDAQ Listing

New York, NY – December 24, 2014 – Press Release: New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented H.C. Wainwright & Co. and Aegis Capital Corp. as underwriters in PlasmaTech Biopharmaceuticals, Inc.’s public offering of 3,500,000 shares of common stock and 3,500,000 warrants. The gross proceeds from the offering were $14,035,000 and the offering price was $4.00 per share and $.01 per warrant. The warrants have a per share exercise price of $5.00 and are exercisable immediately. PlasmaTech common stock and warrants began trading on the NASDAQ Capital Market (effective December 19, 2014) under the symbols “PTBI” and “PTBIW” respectively.

PlasmaTech Biopharmaceuticals, Inc. is a biopharmaceutical company focused on advanced targeted treatments for critical patient care. The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Marcelle Balcombe.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRFC's LinkedIn page

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc. - October 8, 2024
Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering - October 2, 2024
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering - October 2, 2024

Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering

Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering

New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc. - October 8, 2024
Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering - October 2, 2024
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering - October 2, 2024

ContraVir Pharmaceuticals Announces $9.0 Million Private Placement

Sichenzia Ross Friedman Ference LLP Advises ContraVir Pharmaceuticals on $9.0 Million Private Placement

New York, October 28, 2014 (Global Newswire) – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, on a $9 million private placement consisting of Series A Convertible Preferred stock to a non-U.S investor.

Pursuant to the private placement, the Series A Preferred Stock can be converted into shares of common stock at the conversion price of $0.48 per share. The Sichenzia Ross Friedman Ference LLP team was led by partner Jeffrey J. Fessler.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc. - October 8, 2024
Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering - October 2, 2024
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering - October 2, 2024

CEL-SCI Corporation Announces $6.0 Million Public Offering

Sichenzia Ross Friedman Ference LLP Represents CEL-SCI Corporation on $6.0 Million Public Offering

New York, NY – October 29, 2014 – GLOBAL NEWSWIRE – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it has advised Laidlaw & Co. (UK) Ltd. as the Lead Underwriter in a $6 million public Public Offering of CEL-SCI Corporation (NYSE MKT: CVM), a late-stage biotechnology company focused on oncology research and drug development. The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of common stock and warrants at a combined price of $0.76 per unit. Pursuant to the offering, CEL-SCI issued one warrant to purchase common stock for every four shares sold. The warrants have an exercise price of $1.25 per unit. The Sichenzia Ross Friedman Ference LLP team was led by Partner Richard A. Friedman and Associate Stephen Cohen.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc. - October 8, 2024
Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering - October 2, 2024
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering - October 2, 2024

Sichenzia Ross Friedman Ference LLP Advises Labor Smart, Inc. on a $1.1 million Private Placement of Common Stock.

August 18, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Labor Smart, Inc. (OTCBB: LTNC), a provider of on-demand construction, manufacturing and retail staffing , in a $1.1 million private placement pursuant of Regulation D. The transaction consisted of original issue discount debentures convertible at $0.15 per share and 100,000 shares of common stock. The Sichenzia RossFriedman Ference LLP team was led by Gregory Sichenzia and Jeff Cahlon.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc. - October 8, 2024
Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering - October 2, 2024
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering - October 2, 2024

Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..

NEW YORK, April 18, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as sole Placement Agent in a $2.5 million private placement of X2 Bio systems, Inc., a privately held Seattle based science and technology company which is developing the first complete solution for assessing sport brain injuries. The offering consisted of $2.5 million of Units consisting of 6% convertible promissory notes and common stock purchase warrants. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and David Manno.

Media Contact:

pr@srf.law
212-930-9700